Develops ion beam imaging technology to analyze tissue biopsies for advanced cellular and molecular insights.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Ionpath provides high-definition spatial proteomics solutions designed to accelerate research in oncology, immunology, and targeted drug discovery. The company utilizes advanced mass spectrometry imaging technology to scan tissue samples, allowing researchers to visualize dozens of distinct protein biomarkers simultaneously at single-cell resolution. By mapping the intricate cellular architecture of the tissue microenvironment, the platform delivers deeper biological insights to improve disease diagnosis and therapeutic development.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Ionpath Management Team
Investors
Bruker Corporation
Genoa Ventures
ND Capital
Norwich Ventures
Paladin Capital Group
Samsara BioCapital
Trancos IONpath Investors
Vertical Venture Partners
Ionpath Valuations & Financials
View real-time NPM data on Ionpath stock including daily Ionpath stock price estimates, valuation history, and historical share price information. Access Ionpath financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Ionpath pricing across six independent market signals. Looking for private company due diligence data sources on Ionpath? Get in touch to learn more.
Similar Companies
like Ionpath
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
Superblocks
Enterprise Software
Low-code platform for building enterprise internal applications that streamline operations and customer support workflows.
Lumendi
A medical device company that focuses on creating innovative tools to improve the efficacy and safety of endoluminal surgeries.
4C Medical Technologies
Healthcare & Life Sciences
Offers a new class of minimally invasive heart‑valve therapies to expand treatment options and simplify procedures.
Square Footage
Transforms homes by crafting bespoke kitchens, baths, and cohesive interior environments.
Boston Dynamics
AI & Machine Learning
Deploys dynamic machines which traverse complex terrain and assist with physical work in real world settings.
Vacatia
Provides a marketplace for vacation ownership and resort rentals, combining home-like space with hotel services for families and friends.
Cresilon
Healthcare & Life Sciences
Develops plant-based hemostatic gels for rapid bleeding control in veterinary and human care.
CircleCo
Brings creators and their communities together by combining discussions, memberships, and content in one platform.
FAQ
We have answers
Ionpath stock does not trade on public stock exchanges. Ionpath stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Ionpath stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Ionpath Stock does not trade on public stock exchanges. In order to sell Ionpath shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Ionpath does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Ionpath share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Ionpath stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Ionpath stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Ionpath stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Ionpath is a private company and has not had an IPO. There is currently no Ionpath IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Ionpath IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
